All News NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

Market Closed - Nasdaq Other stock markets 02:00:00 11/05/2024 am IST			5-day change	1st Jan Change
0.1393 ^USD	-1.55%		+0.94%	-76.39%

08/04	Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors	CI
03/04	NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors	09/04	CI
NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding	03/04	CI
NLS Pharmaceutics : Various Claims Against the Company - Form 6-K	20/03	PU
NLS Pharmaceutics : SECOND ADDENDUM TO THE - Form 6-K	20/03	PU
NLS Pharmaceutics Ltd. announced that it expects to receive $1.75 million in funding	20/03	CI
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event	15/03	AQ
NLS Pharmaceutics Submits Plan to Regain Listing Compliance with Nasdaq	26/02	AQ
NLS Pharmaceutics Files Plan to Regain Nasdaq Listing Compliance	23/02	MT
NLS Pharmaceutics - Notice of Deficiency with Nasdaq Continued Listing Requirements	15/01	AQ
Press release titled: “NLS Pharmaceutics CEO Issues Letter to Shareholders.” - Form 6-K	30/12	PU
NLS Pharmaceutics : Ordinary Shareholders’ Meeting Results - Form 6-K	23/12	PU
NLS Pharmaceutics : UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS - Form 6-K	07/12	PU
NLS Pharmaceutics AG Reports Earnings Results for the Half Year Ended June 30, 2023	07/12	CI
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	02/12	MT
Sector Update: Health Care Stocks Rise in Afternoon Trading	02/12	MT
Top Midday Gainers	02/12	MT
NLS Pharmaceutics Signs Option Agreement to Acquire Rights to Aexon Labs' Assets; Shares Rise	01/12	MT
NLS Pharmaceutics Announces Election of Additional Board Members	29/11	AQ
NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit, Deep Dive into Narcolepsy and Idiopathic Hypersomnia	28/11	AQ
NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan	17/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

All News

Filters